ESAB Corporation Announces Second Quarter 2023 Results

Record sales and margin performance



Sales up 9% with core organic growth of 6%



Reported net income from continuing operations attributable to ESAB of $67 million and core adjusted EBITDA of...

Related Keywords

Russia ,United States ,Ohio ,Ukraine ,Maryland ,North Bethesda ,America ,Shyamp Kambeyanda , ,Enovis Corporation ,Company Annual Report On Form ,Exchange Commission ,Ohio Medical ,Therapy Equipment ,Full Year ,Securities Litigation Reform Act ,Annual Report ,Months Ended June ,Combined Condensed Statements ,Combined Statements ,Former Parent ,